Skip to content

Enhancement of healing for extruded injured meniscus by transplantation of synovial stem cells after meniscus surgery.

Enhancement of healing for extruded injured meniscus by transplantation of synovial stem cells after meniscus surgery. - Enhancement of healing for extruded injured meniscus by transplantation of synovial stem cells after meniscus surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017890
Enrollment
10
Registered
2015-06-12
Start date
2015-07-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee meniscal tear

Interventions

Arthroscopic transplantation of synovial MSCs after meniscus repair with centralization technique

Sponsors

Medical Hospital of Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Extruded meniscus injury with radial, horizontal, degenerative tear etc. to which meniscal resection is generally indicated 2) Patients with clinical symptoms such as knee joint unstability, limitation in range of motion, hydrarthrosis and pain 3) Patients suitable for surgery 4) Patients to whom meniscal repair is technically possible 5) Patients older than 20 years on the acquisition date of informed consent before clinical study 6) Patients who gave a written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who didn't give a written informed consent 2) Patients with active infection 3) Patients positive for HIV (HIV-1, 2 Ag, Ab), HBV (HBs Ag), HCV (HCV Ab), or HTLV-1 (HTLV-1 Ab) 4) Patients with active malignant tumors 5) Patients sensitive to antibiotic 6) Pregnant or breast-feeding women 7) Patients with diabetes 8) Patients in bad general physical condition 9) When doctors decide as not appropriate to participate in the clinical study

Design outcomes

Primary

MeasureTime frame
Adverse event data, including type, frequency, severity and duration

Secondary

MeasureTime frame
1) Safety of the autologous synovial mesenchymal stem cells 2) Subjective score by KOOS and NRS, Observation of knee, Knee functional evaluation by McMurry test and pivot shift test, Lysholm score 3) MRI examination 4) Knee X-ray examination

Countries

Japan

Contacts

Public ContactOffice administrator

Medical Hospital of Tokyo Medical and Dental University Clinical Research Center

tiken.crc@tmd.ac.jp03-5803-5612

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026